Published in Nephron on December 01, 2001
Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol (2012) 1.00
Cryptococcosis in HIV-negative Patients with Renal Dialysis: A Retrospective Analysis of Pooled Cases. Mycopathologia (2017) 0.75
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28
Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80
The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54
Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38
Survival advantage in Asian American end-stage renal disease patients. Kidney Int (1999) 1.98
Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: a randomized trial. Gastroenterology (1999) 1.91
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90
Effectiveness and patient satisfaction with screening flexible sigmoidoscopy performed by registered nurses. Gastrointest Endosc (1999) 1.89
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67
Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant (2001) 1.60
A probability model of vector behavior: effects of DDT repellency, irritancy, and toxicity in malaria control. J Vector Ecol (2000) 1.57
Body size, dose of hemodialysis, and mortality. Am J Kidney Dis (2000) 1.48
Bedside blood glucose determinations in critical care medicine: a comparative analysis of two techniques. Crit Care Med (1982) 1.46
Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials (1996) 1.42
Liver cysts in patients with autosomal dominant polycystic kidney disease. Am J Med (1980) 1.41
Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation (1998) 1.35
The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med (1994) 1.26
Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. Lab Invest (1990) 1.20
Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study. Am J Kidney Dis (2001) 1.17
Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol (1990) 1.17
Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension (1997) 1.16
Training of providers in embryo transfer: what is the minimum number of transfers required for proficiency? Hum Reprod (2001) 1.14
Precipitating antigen-antibody systems are required for the formation of subepithelial electron-dense immune deposits in rat glomeruli. J Exp Med (1983) 1.11
Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol (2002) 1.11
Hospitalizations for bacterial septicemia after renal transplantation in the united states. Am J Nephrol (2001) 1.11
Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines. Vaccine (2000) 1.11
Rearrangement of immune complexes in glomeruli leads to persistence and development of electron-dense deposits. J Exp Med (1983) 1.09
Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study. Kidney Int (1997) 1.07
Reductions in herpes simplex virus type 2 antibody titers after cognitive behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social support in HIV-positive men. Psychosom Med (2001) 1.04
Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol (1999) 1.02
Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol (2001) 1.02
Hospitalizations for fractures after renal transplantation in the United States. Ann Epidemiol (2001) 1.02
Relationship of dialysis membrane and cause-specific mortality. Am J Kidney Dis (1999) 1.01
Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation (2000) 1.01
Renal transplantation in end-stage sickle cell nephropathy. Transplantation (1999) 1.01
Effect of an evidence-based medicine seminar on participants' interpretations of clinical trials: a pilot study. Acad Med (2000) 1.00
Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis (2001) 1.00
Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis (2001) 0.99
Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. Am J Kidney Dis (1999) 0.95
The United States Renal Data System's 1991 annual data report: an introduction. Am J Kidney Dis (1991) 0.94
Effects of hemodialyzer reuse on clearances of urea and beta2-microglobulin. The Hemodialysis (HEMO) Study Group. J Am Soc Nephrol (1999) 0.93
Autosomal dominant polycystic kidney disease: symptoms and clinical findings. Q J Med (1984) 0.92
Hospitalizations for bacterial endocarditis after renal transplantation in the United States. J Nephrol (2001) 0.92
Relationship of glomerular hypertrophy and sclerosis: studies in SV40 transgenic mice. Kidney Int (1990) 0.92
Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients. Kidney Int (2000) 0.92
Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol (2002) 0.91
Methods of testing and analyzing excito-repellency responses of malaria vectors to insecticides. J Am Mosq Control Assoc (1997) 0.91
Intrafamilial phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis (1992) 0.90
Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System. Transpl Infect Dis (2002) 0.89
Dialysis modality and the risk of allograft thrombosis in adult renal transplant recipients. Kidney Int (1999) 0.88
Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients--an analysis of USRDS data. Am J Transplant (2007) 0.88
Fertility and pregnancy complications in women with autosomal dominant polycystic kidney disease. Obstet Gynecol (1983) 0.87
Antibody localization in the glomerular basement membrane may precede in situ immune deposit formation in rat glomeruli. J Immunol (1985) 0.87
A critical examination of trends in outcomes over the last decade. Am J Kidney Dis (1998) 0.86
Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis (2000) 0.86
Immune complexes with cationic antibodies deposit in glomeruli more effectively than cationic antibodies alone. J Immunol (1987) 0.86
Multiple-dose vials: persistence of bacterial contaminants and infection control implications. Infect Control (1985) 0.86
Risk factors for hospitalizations resulting from pulmonary embolism after renal transplantation in the United States. J Nephrol (2001) 0.85
Hospitalized valvular heart disease in patients on renal transplant waiting list: incidence, clinical correlates and outcomes. Clin Nephrol (2003) 0.85
Prognosis after hospitalization for acute myocardial infarction not accompanied by typical ischemic chest pain. The Multicenter Diltiazem Postinfarction Trial Research Group. Am J Med (1995) 0.85
Potential causes and pathogenesis in autosomal dominant polycystic kidney disease. Nephron (1983) 0.84
Etiology of bacterial septicemia in chronic dialysis patients in the United States. Clin Nephrol (2001) 0.84
Measurement of perceived disruption during rebuilding following Hurricane Andrew. J Trauma Stress (1997) 0.83
Plasma, urine, and CSF catecholamine concentrations during and after ketamine anesthesia. Crit Care Med (1982) 0.83
Peripheral serotonin levels in women: role of aging and ethnicity. Gerontology (1998) 0.82
Double-blind, placebo-controlled, crossover trial of propranolol as treatment for menopausal vasomotor symptoms. Clin Ther (1981) 0.82
The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes. J Nephrol (2001) 0.81
Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study. Am J Kidney Dis (1997) 0.81
Characteristics and treatment of patients not reusing dialyzers in reuse units. Am J Kidney Dis (2000) 0.80
Introduction to the excerpts from the United States Renal Data System 1999 Annual Data Report. Am J Kidney Dis (1999) 0.80
Removal of subepithelial immune complexes with excess unaltered or cationic antigen. Kidney Int (1987) 0.79
Clinical manifestations of autosomal dominant polycystic kidney disease in patients older than 50 years. Am J Kidney Dis (1990) 0.79
The effect of decreasing digital image resolution on teledermatology diagnosis. Telemed J (1999) 0.79
The effect of propranolol on catecholamine clearance. Clin Pharmacol Ther (1986) 0.79
High-dose magnesium sulfate attenuates pulmonary oxygen toxicity. Crit Care Med (1992) 0.79
Early normalization of platelet survival by endothelial seeding of Dacron arterial prostheses in dogs. Surgery (1982) 0.79
[Practical guidelines for the management of Ebola infected patients in the field]. Med Trop (Mars) (2004) 0.78
Serum creatinine levels in older adults: relationship with health status and medications. Age Ageing (1995) 0.77
Growth rates in pediatric dialysis patients and renal transplant recipients. Am J Kidney Dis (1997) 0.76
Epidemiology of acute hepatitis in the Stann Creek District of Belize, Central America. Am J Trop Med Hyg (2001) 0.75
The role of pretransplant time and therapy on kidney graft survival. Clin Transpl (1989) 0.75
The United States Renal Data System's 1990 Annual Data Report: an introduction. Am J Kidney Dis (1990) 0.75
Impact of managed care on obstetrician-gynecologists' practice: the providers' perspective. Womens Health Issues (2001) 0.75